glp-1 news 2025 october 16 Mapping the effectiveness and risks of receptor agonists ISPOR 2025: Exploring reasons for

Aviles-Olmos, I., Dickson, J., Kefalopoulou, Z., et al

More work is needed to figure out how each drug gets across the barrier and what that means for treatment

Summary Although GLP-1R agonists were originally developed for glycemic control in DM, their mechanistic versatility has enabled broader application across a spectrum of cardiovascular, cerebrovascular and metabolic disorders

Want to know more about oral GLP-1s

Practical hydration strategies: Aim for consistent fluid intake : The NHS Eatwell Guide recommends 68 glasses (approximately 1.2 litres) of fluid daily, though individual needs vary based on activity level, climate, and health status